MONSTA Xs 3rd all-English album, Unfold, is now out, telling an emotional journey of the evolution of love, heartbreak, and healing, with lead single, "heal."
Die kanadische Bank RBC hat die Einstufung für Tesla nach Auslieferungszahlen des Elektroautobauers für das erste Quartal auf "Outperform" mit einem Kursziel von 500 US-Dollar belassen. Diese hätten die Markterwartung ...
For all intents and purposes, the play-in round is on ahead of the 2026 Stanley Cup Playoffs. Three teams are vying for one spot in both NHL conferences.
The directorial debut of BriTANicK comedy duo Brian McElhaney and Nick Kocher is a drug-fueled odyssey in the vein of Harold and Kumar Go To White Castle.
PENNSAUKEN, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty healthcare, and information technology services, today announced financial results for the fourteen and fifty-three weeks ended January 3, 2026.
Außerdem holt die Bayern LB einen Finanzvorstand aus den Niederlanden, in Brüssel gibt es einen Wechsel von der Commerzbank zu JP Morgan und in der OLB eine Reihe von Abgängen im Vorstand. Was die Finanzwelt Anfang April bewegt: Schon gehört, dass...?
Kandi Burruss and Todd Tucker just amicably finalized their divorce. Heres a breakdown of their prenup dispute, the $426,000 payout, and their co-parenting terms.
WILMINGTON, Del., April 03, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to purchase up to an aggregate of 685,718 shares of the Company’s common stock to five newly-hired non-executive employees under the Company’s 2026 Inducement Equity Plan (the “Inducement Plan”), effective as of March 31, 2026 (the “Effective Date”). The inducement grants were previously approved by th...
HOUSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO) announced that its annual report(10-K) for the fiscal year ending December 31, 2025, filed on March 11, 2026, includes an audit opinion from Grassi & Co., CPAs, P.C. that contains a "going concern" qualification. This announcement is made pursuant to NYSE American LLC Company Guide Section 610(b), which requires public announcement of the receipt of an audit opinion containing a going concern paragraph and ...
Angesichts der Krise auf dem Wohnungsmarkt legt Vizekanzler Klingbeil Details für eine staatliche Lösung vor. Eine neue Organisation soll den Bau von preiswerten Immobilien vorantreiben, ohne selbst zur Baufirma zu werden. Doch für das Vorhaben wäre eine Grundgesetzänderung nötig.
The U.S. Navy’s largest aircraft carrier is likely to remain in the Middle East, as additional warships and U.S. Air Force aircraft are sent to the region.
Dont let the Iran conflict or AI anxiety distract you. Market dips are healthy and often lead to major bounces. Kevin Matras will keep you focused and ready to capitalize on a fourth year of double-digit growth.
“Reasons to worry.” That is Wells Fargo CEO Charles Scharf’s curt, three-word take on the U.S. economy, despite reiterating the strength of the current macro backdrop. Consumers are still spending, employment numbers remain relatively strong, and wages are growing, meaning businesses are ...
Strategic investments in Orlando and Tampa increase the firm’s Central Florida footprint to 35 properties spanning 145.2 usable acres Strategic investments in Orlando and Tampa increase the firm’s Central Florida footprint to 35 properties spanning 145.2 usable acres
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Northern Trust (NTRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
U.S. Bancorp (USB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
HF Sinclair (DINO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Constellation Brands (STZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Matador (MTDR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Polaris Inc (PII) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
KeyCorp (KEY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Las Vegas Sands (LVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Virtu Financial (VIRT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The PNC Financial Services Group (PNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ATI (ATI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Alps Electric (APELY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Vivani Medical (VANI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Agenus (AGEN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
W.P. Carey (WPC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Global Payments (GPN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Galectin Therapeutics (GALT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Applied Materials (AMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
60 Degrees Pharmaceuticals Inc. (SXTP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Allbirds, Inc. (BIRD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.